Diginex Faces Uphill Battle in Strategic Overhaul

Shares of Diginex traded at €0.76 on Saturday, offering a faint glimmer after a catastrophic year that saw the stock plummet 88%. The company is attempting a strategic reset under new leadership, supported by recent acquisitions and high-profile shareholders including Visa and Deutsche Bank. However, the underlying financials paint a stark picture: with revenue of $2 million starkly contrasted by a negative EBITDA of $8 million.

The company's market capitalization currently sits in a range of $175 to $212 million. The share price lingers just above its 52-week low of €0.72, a far cry from its annual high of €35.50. This extreme volatility underscores a significant erosion of investor confidence. The core financial struggle is captured in the figures for the 2024/25 fiscal year, where modest revenue is overwhelmed by substantial operational losses.

New Leadership at the Helm

A central part of the turnaround strategy is the appointment of Lubomila Jordanova as Chief Executive Officer on January 28. Her primary mandate is to drive the integration of two recently completed acquisitions: "Plan A" and "The Remedy Project." These purchases are designed to bolster Diginex's ESG data management division, targeting a growing yet fiercely competitive market segment.

In a related strategic move, Diginex has signed a framework agreement to establish a joint venture in Brazil's Mato Grosso state, focused on building ESG infrastructure. Specifics regarding funding and implementation timelines remain undisclosed.

Should investors sell immediately? Or is it worth buying Diginex?

High-Profile Backers Bring Scrutiny

The recent corporate moves have brought financial heavyweights Visa and Deutsche Bank into the shareholder registry. While their involvement could potentially open doors to valuable networks and partnerships, it also amplifies the performance pressure on Jordanova and her executive team. The market will be watching closely to see if these stakes translate into tangible commercial advantages.

Key Data Points:
* Current Share Price: €0.76 (Tradegate)
* Year-to-Date Performance: -88%
* Annual Revenue (2024/25): $2.04 million
* EBITDA: -$8 million
* Market Capitalization Range: $175-212 million
* Notable New Shareholders: Visa, Deutsche Bank

The strategic pivot led by Jordanova now faces a critical test. With the fiscal year ending on March 31, 2026, the company has a limited window to demonstrate that its acquisitions represent a solid foundation for growth, not merely an attempt to capitalize on the ESG trend. Proving that the operational base is robust enough to support a genuine recovery remains the paramount challenge.